Plus Therapeutics
Omar Algunaid possesses extensive experience in the pharmaceutical and biotechnology sectors, currently serving as CMC Manager at Plus Therapeutics, Inc. since September 2018, where responsibilities include advising on new manufacturing technologies, leading cross-functional teams, overseeing technology transfer to contract manufacturers, and conducting critical process validations. Prior roles at Takeda Oncology involved support in manufacturing drug products, process optimization, and regulatory documentation, while earlier experience at EcoSeal LLC included R&D for a green pesticide. Omar holds a Bachelor's Degree in Chemical Engineering from UCLA.
This person is not in any teams
Plus Therapeutics
Plus Therapeutics (Nasdaq: PSTV) is a U.S. clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for rare and difficult-to-treat cancers.